EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma
K. Voeltzke, K. Scharov, C. Funk, A. Kahler, D. Picard, L. Hauffe, M. F. Orth, M. Remke, I. Esposito, T. Kirchner, A. Schramm, B. Rotblat, T. G. P. Gruenewald, G. Reifenberger, G. Leprivier
This study shows EIF4EBP1 is upregulated by MYCN and linked to poor prognosis in neuroblastoma, with high expression associated with reduced survival and unfavorable histology.
bioRxiv · Dec 8, 2021Cancer Biology